TB 500 5mg
In stock
TB-500 5mg is supplied as a thymosin-related research vial. Interest in this field centres on peptide structure and cellular movement, with full-length thymosin beta-4 studies and TB-500 fragment studies addressing different molecular materials.
TB-500 and the study of cellular movement
TB-500 5mg is linked to a research field exploring how thymosin-related peptides interact with the biology of movement and repair. The parent molecule, thymosin beta-4, is involved in actin organisation, providing a mechanistic starting point for these questions.
What parent-peptide studies contribute
Experiments with full-length thymosin beta-4 have examined actin sequestration and coordinated changes in cytoskeletal proteins. This work helps explain why the wider peptide family attracts interest in cell migration and tissue responses.
Analytical researchers have also identified a shorter N-acetylated LKKTETQ sequence in material called TB-500. That segment corresponds to residues 17-23 of the parent peptide. Studying such fragments allows investigation of the relationship between a selected sequence and the properties of the larger molecule.
Matching evidence to the supplied material
The TB-500 name has been used for different thymosin-related products. Sequence confirmation is not included in the supplied information for this 5mg vial, so no fragment or full-length equivalence is assumed.
The research interest is clear, but parent-peptide findings remain background rather than direct proof of human recovery benefits from TB-500. The 5mg amount distinguishes this catalogue variant without implying a separately demonstrated biological effect.
Also known as / branded as
- TB-500
- TB500
| Dynamic Performance Range | Dynamic Performance: Peptides |
|---|








